Free Newsletter
We're keeping up with you
Welcome to the first of FiercePharma Manufacturing's two issues this week! Your email in-box on Thursday will contain issue #2.

We're upping the frequency for two reasons. First is the need to keep pace with developments in pharmaceutical and bioprocessing operations. In spite of the poor economy, we've seen the industry gain momentum since we launched last summer. Business collaborations, facility openings, manufacturing practice updates, and supply chain advances are coming at us too quickly and at too great a volume to warrant just once-a-week coverage.
Second, our subscriber rolls have grown beyond our expectations. Although that's not by itself an indicator for a frequency increase, it's been accompanied by a swell of interest and participation from manufacturing service providers, product vendors, and industry groups--all of whom have something they want to say to you.
So enjoy this first of two issues this week. And know that you'll get another briefing as the week comes to a close.
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




